Medicare Pricing Delay is Political Win for Amgen, Drug Maker
Saturday, January 19, 2013 - 23:10
in Mathematics & Economics
A provision buried in the fiscal bill passed earlier this month gives Amgen, the world’s largest biotechnology firm, more time to sell a lucrative kidney dialysis drug without price restraints.